CJC-1295 No DAC & Ipamorelin

CJC-1295 No DAC & Ipamorelin combines two synthetic research peptides studied for their activity within growth hormone signaling pathways. CJC-1295 No DAC is a GHRH analogue investigated for its interaction with growth hormone-releasing hormone receptors, while Ipamorelin is a growth hormone secretagogue studied for its activity at the ghrelin (GHS-R1a) receptor.

Research involving these compounds has explored growth hormone signaling, pituitary response, pulsatile hormone release, endocrine signaling, and metabolic pathways. The combination is of particular research interest because the two peptides act through distinct signaling mechanisms associated with growth hormone release.

Research Focus: GHRH Signaling • Ghrelin Receptor Signaling • Growth Hormone Research • Pituitary Function • Endocrine & Metabolic Research

CJC-1295 & Ipamorelin Canada Research Information: North America Peptides provides lot-specific product information and available COA documentation for research reference.

For research use only. Not intended for human or veterinary use.